FDA Proposes Rule to Preempt State Drug Product Liability Laws

WASHINGTON, D.C. - The Food and Drug Administration is attempting to revise its rule on prescription drug labeling by inserting language to override state product liability laws.

Susan Frederick of the National Conference of State Legislatures told HarrisMartin that the organization's liaison in the Department of Health and Human Services recently informed the NCSL of the proposed rule.

The FDA declined to release a copy of the new proposal to HarrisMartin.

The notice of proposed rulemaking on Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Prescription Drug Product Labels (Docket No. 00N-1269) was first issued …